Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D
Institut Gustave Roussy, Villejuif, France.
Fertil Steril. 2000 Oct;74(4):743-8. doi: 10.1016/s0015-0282(00)01500-4.
To assess the indications, effectiveness, and complications of ovarian transposition before pelvic irradiation for cervical cancer.
Prospective study.
Gynecologic oncology department at a French cancer center.
PATIENT(S): One hundred seven patients treated for cervical cancer.
INTERVENTION(S): Ovarian transposition to the paracolic gutters with radical hysterectomy and lymphadenectomy.
MAIN OUTCOME MEASURE(S): Clinical and laboratory follow-up tests for ovarian function.
RESULT(S): Bilateral ovarian transposition was achieved in 104 patients (98%). Twelve patients were lost to follow-up or excluded because of evolution of the disease. Preservation of ovarian function was achieved in 83% of the patients having follow-up. The rates of ovarian preservation were 100% for patients treated exclusively by surgery, 90% for patients treated by postoperative vaginal brachytherapy, and 60% for patients treated by postoperative external radiation therapy and vaginal brachytherapy. The main risk for ovarian failure was found in patients treated by external radiation therapy.
CONCLUSION(S): Ovarian transposition is a safe and effective procedure for preserving ovarian function in patients treated by a radiosurgical combination. This procedure should be performed in patients <40 years of age with a small invasive cervical carcinoma (<3 cm) treated by initial surgery. In such selected cases, the risk of ovarian metastasis is low.
评估宫颈癌盆腔放疗前卵巢移位术的适应证、有效性及并发症。
前瞻性研究。
法国一家癌症中心的妇科肿瘤科。
107例宫颈癌患者。
在根治性子宫切除术及淋巴结清扫术时将卵巢移位至结肠旁沟。
卵巢功能的临床及实验室随访检查。
104例患者(98%)成功进行了双侧卵巢移位。12例患者因病情进展失访或被排除。在有随访的患者中,83%实现了卵巢功能保留。单纯接受手术治疗的患者卵巢保留率为100%,接受术后阴道近距离放疗的患者为90%,接受术后体外放疗及阴道近距离放疗的患者为60%。卵巢功能衰竭的主要风险见于接受体外放疗的患者。
卵巢移位术对于接受放疗与手术联合治疗的患者而言是一种安全有效的保留卵巢功能的方法。该手术应在年龄<40岁、初始手术治疗的微小浸润性宫颈癌(<3 cm)患者中进行。在这类选定的病例中,卵巢转移风险较低。